Health Product Shortages homepage

Welcome to Health Product Shortages Canada, the website for mandatory reporting of health product shortages and discontinuations by regulated parties. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the health products they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca (open in new tab).

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

List of shortage reports
Brand name Company Name Status Strength Update Date Updated View Report
SANDOZ PIRFENIDONE CAPSULES SANDOZ CANADA INCORPORATED Anticipated shortage 267MG New Report 2026-03-16 280585
SANDOZ MOXIFLOXACIN SANDOZ CANADA INCORPORATED Anticipated shortage 0.5% New Report 2026-03-16 280582
SANDOZ IRBESARTAN SANDOZ CANADA INCORPORATED Anticipated shortage 300MG New Report 2026-03-16 280579
SANDOZ IRBESARTAN HCT SANDOZ CANADA INCORPORATED Anticipated shortage 12.5MG 150MG New Report 2026-03-16 280576
ESTRADOT 37.5 SANDOZ CANADA INCORPORATED Anticipated shortage 37.5MCG New Report 2026-03-16 280573
SANDOZ ESTRADIOL DERM 50 SANDOZ CANADA INCORPORATED Actual shortage 50MCG Updated Report 2026-03-16 279260
SANDOZ ESOMEPRAZOLE SANDOZ CANADA INCORPORATED Anticipated shortage 40MG New Report 2026-03-16 280568
DAPTOMYCIN FOR INJECTION SANDOZ CANADA INCORPORATED Anticipated shortage 500MG New Report 2026-03-16 280565
ESTRADOT 75 SANDOZ CANADA INCORPORATED Actual shortage 75MCG Updated Report 2026-03-16 276715
ESTRADOT 50 SANDOZ CANADA INCORPORATED Actual shortage 50MCG Updated Report 2026-03-16 276712

Discontinuation Reports

List of discontinuation reports
Brand name Company Name Status Strength Update Date Updated View Report
ATIVAN PFIZER CANADA ULC Discontinued 1MG Updated Report 2026-03-13 269846
ATIVAN PFIZER CANADA ULC Discontinued 0.5MG Updated Report 2026-03-13 269843
RATIO-TOPISALIC TEVA CANADA LIMITED Discontinued 0.5MG 20MG New Report 2026-03-13 280453
CANCIDAS MERCK CANADA INC To be discontinued 50MG Updated Report 2026-03-12 273084
CANCIDAS MERCK CANADA INC To be discontinued 70MG Updated Report 2026-03-12 273087
Get it on Google Play Download on the App Store